Literature DB >> 24665138

Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness.

Jacqui Wise1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24665138     DOI: 10.1136/bmj.g2327

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Bexsero® chronicle.

Authors:  George Vernikos; Duccio Medini
Journal:  Pathog Glob Health       Date:  2014-10       Impact factor: 2.894

2.  Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel.

Authors:  Gary M Ginsberg; Colin Block; Chen Stein-Zamir
Journal:  Int J Public Health       Date:  2016-04-22       Impact factor: 3.380

Review 3.  Evolving measles status and immunization policy development in six European countries.

Authors:  Ivo Vojtek; Heidi Larson; Stanley Plotkin; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2022-02-18       Impact factor: 4.526

Review 4.  Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States.

Authors:  Angelika Banzhoff
Journal:  Ther Adv Vaccines       Date:  2017-01-06

5.  Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines.

Authors:  Lorenzo Argante; Michele Tizzoni; Duccio Medini
Journal:  BMC Med       Date:  2016-06-30       Impact factor: 8.775

6.  Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement.

Authors:  Cosmina Hogea; Thierry Van Effelterre; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.